Meta-Analysis of Randomized Controlled Trials on the Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer’s Disease

To study the impact of donepezil, rivastigmine, galantamine, and memantine on cognitive, functional, behavioral, global changes and adverse effects in patients with mild, moderate and severe Alzheimer’s disease (AD), we screened the literature published before September 2017 in the Pubmed, Embase, C...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Dan-Dan, Zhang, Ya-Hong, Zhang, Wei, Zhao, Pu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529534/
https://www.ncbi.nlm.nih.gov/pubmed/31156366
http://dx.doi.org/10.3389/fnins.2019.00472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529534/
https://www.ncbi.nlm.nih.gov/pubmed/31156366
http://dx.doi.org/10.3389/fnins.2019.00472

Ejemplares similares